2008Chinese Journal of Hospital PharmacyRequires access

Bioavailability study of ciprofloxacin hydrochloride intra-gastric floating sustained release tablets in dogs

Gengliang Yang

Open publisher page 0 citations

Abstract

OBJECTIVE To study the pharmacokinetics and bioavailability of ciprofloxacin hydrochloride intra-gastric floating sustained release tablets and its conventional tablets in six male dogs.METHODS The concentrations of ciprofloxacin hydrochloride in plasma were determined by HPLC method.The main pharmacokinetic parameters of relative bioavailability of the sustained release capsules were obtained using 3P87 program.RESULTS The Cmax of the two preparations were(3.7±0.7)mg·L-1 and(2.5±0.8)mg·L-1respectively;tmax were(1.8±0.8)h and(3.7±0.5)h and MRT were(5.7±0.5)h,(7.5±0.7)h respectively.AUC0→24 were(20.5±3.7)mg·h·L-1 and(21.4±4.7)mg·h·L-1,The relative bioavailability of the sustained-release tablets was 104.2%.CONCLUSION By the statistical analysis,the ciprofloxacin hydrochloride intra-gastric floating sustained release tablets have good sustained release characteristics and were bioequivalent to the reference formulation.

About this research paper

What this paper is about

OBJECTIVE To study the pharmacokinetics and bioavailability of ciprofloxacin hydrochloride intra-gastric floating sustained release tablets and its conventional tablets in six male dogs.METHODS The concentrations of ciprofloxacin hydrochloride in plasma were determined by HPLC method.The main pharmacokinetic parameters of relative bioavailability of the sustained release capsules were obtained using 3P87 program.RESULTS The Cmax of the two preparations were(3.7±0.7)mg·L-1 and(2.5±0.8)mg·L-1respectively;tmax were(1.8±0.8)h and(3.7±0.5)h and MRT were(5.7±0.5)h,(7.5±0.7)h respectively.AUC0→24 were(20.5±3.7)mg·h·L-1 and(21.4±4.7)mg·h·L-1,The relative bioavailability of the sustained-release tablets was 104.2%.CONCLUSION By the statistical analysis,the ciprofloxacin hydrochloride intra-gastric floating sustained release tablets have good sustained release characteristics and were bioequivalent to the reference formulation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To study the pharmacokinetics and bioavailability of ciprofloxacin hydrochloride intra-gastric floating sustained release tablets and its conventional tablets in six male dogs.METHODS The concentrations of ciprofloxacin hydrochloride in plasma were determined by HPLC method.The main pharmacokinetic parameters of relative bioavailability of the sustained release capsules were obtained using 3P87 program.RESULTS The Cmax of the two preparations were(3.7±0.7)mg·L-1 and(2.5±0.8)mg·L-1respectively;tmax were(1.8±0.8)h and(3.7±0.5)h and MRT were(5.7±0.5)h,(7.5±0.7)h respectively.AUC0→24 were(20.5±3.7)mg·h·L-1 and(21.4±4.7)mg·h·L-1,The relative bioavailability of the sustained-release tablets was 104.2%.CONCLUSION By the statistical analysis,the ciprofloxacin hydrochloride intra-gastric floating sustained release tablets have good sustained release characteristics and were bioequivalent to the reference formulation.

Key concepts: Ciprofloxacin Hydrochloride, Bioavailability, Cmax, Bioequivalence, Pharmacokinetics, Chemistry, Pharmacology, Ciprofloxacin

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioavailability study of ciprofloxacin hydrochloride intra-gastric floating sustained release tablets in dogs — Research Paper | ScholarLens